SCHEMBL10038579

SCHEMBL10038579

FC(F)(F)c1cc(C(F)(F)F)c2ccc(-n3c4ccccc4c4ccccc43)cc2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.43
CYP1A2 P05177 2/20 0.42
BACE1 P56817 1/20 0.42
ALDH1A1 P00352 4/20 0.40
KMT2A Q03164 3/20 0.40
KDM4E B2RXH2 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
HTT P42858 3/20 0.39
LMNA P02545 2/20 0.39
MEN1 O00255 2/20 0.39
GAA P10253 3/20 0.38
RAB9A P51151 1/20 0.38
ADRB2 P07550 1/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ADORA2A P29274 1/20 0.37
ADORA1 P30542 1/20 0.37
TNF P01375 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10005316 0.85 BACE1 (0.41) MAPTCYP1A2BACE1ALDH1A1KMT2A
SCHEMBL3300391 0.77 BACE1 (0.66) MAPTCYP1A2BACE1ALDH1A1KMT2A
SCHEMBL13866648 0.73 KDM4E (0.47) BACE1KDM4EGAAATML3MBTL1
SCHEMBL21131815 0.73 KDM4E (0.43) KDM4EATML3MBTL1KIF11
SCHEMBL21132054 0.73 KDM4E (0.43) KDM4EATML3MBTL1KIF11
SCHEMBL21132055 0.73 KDM4E (0.43) KDM4EATML3MBTL1KIF11
SCHEMBL21131814 0.73 KDM4E (0.43) KDM4EATML3MBTL1KIF11
SCHEMBL17563165 0.71 KDM4E (0.42) ALDH1A1KMT2AKDM4ESMN1; SMN2CYP3A4
SCHEMBL19270032 0.71 KDM4E (0.42) KDM4EATML3MBTL1KIF11
SCHEMBL19270916 0.71 KDM4E (0.42) KDM4EATML3MBTL1KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8106206-B2 Solid luminescent quinoline compounds KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2012-01-31 US disclosed
US-20110263861-A1 QUINOLINE COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2011-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263861-A1 QUINOLINE COMPOUND GTF3C3, GTF3C2, GTF3C1 MAPT 3796/4885CYP1A2 666/4885BACE1 4769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.